Quick Takeaways
- This page summarizes Stephen Feider's Form 4 filing for Beta Bionics, Inc. (BBNX).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 31 Jan 2025, 16:30.
Stephen Feider - 29 Jan 2025 Form 4 Insider Report for Beta Bionics, Inc. (BBNX)
- Signature
- /s/ Stephen Feider
- Issuer symbol
- BBNX
- Transactions as of
- 29 Jan 2025
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 31 Jan 2025, 16:30:36 UTC
- Next filing
- 03 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Stephen Feider filed Form 4 for Beta Bionics, Inc. (BBNX) on 31 Jan 2025."
What Changed
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BBNX | Employee Stock Option (right to buy) | Award | $0 | +186,203 | $0.000000 | 186,203 | 29 Jan 2025 | Class B Common Stock | 186,203 | $17.00 | Direct | F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts. |
| F2 | Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. |